Domatinostat Targets the FOXM1–Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents

The deregulation of the FOXM1 transcription factor is a key molecular alteration in ovarian cancer, contributing to the development and progression of ovarian cancer via activation of the target genes. As such, FOXM1 is a highly attractive therapeutic target in the treatment of ovarian cancer, but t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa-Saito, Yurika, Mitobe, Yuta, Suzuki, Shuhei, Togashi, Keita, Sugai, Asuka, Kitanaka, Chifumi, Okada, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341571/
https://www.ncbi.nlm.nih.gov/pubmed/37445993
http://dx.doi.org/10.3390/ijms241310817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341571/
https://www.ncbi.nlm.nih.gov/pubmed/37445993
http://dx.doi.org/10.3390/ijms241310817

Ejemplares similares